Document ID: chunk:federal_register_of_legislation:F2024C00984:reg:86
Version: federal_register_of_legislation:F2024C00984
Segment Type: reg
Provision Reference: reg 86
Character Range: 156024–157159

86  Application provision for the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2023
 (1) The amendments of this instrument made by the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2023 apply in relation to the following:
 (a) if a notice of intent in relation to an application or a submission for the provision of services is not required—an application or a submission (including a remade application or submission) that is received by the Department on or after 1 July 2023;
 (b) in any other case—an application or a submission (including a remade application or submission) for the provision of services, for which a notice of intent is given on or after 1 July 2023.
 (2) In this section:
services means any of the following:
 (a) ATAGI advice;
 (b) the service of the Department holding a pre‑submission meeting with a person;
 (c) submission services;
 (d) pricing services;
 (e) list management services.

Division 4—Amendments made by the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2024